Rite Aid Corp (RAD) Comps Fell 2.2% in December
Tweet Send to a FriendGet Alerts RAD Hot Sheet
Up)
Trade RAD Now!
Rite Aid Corporation (NYSE: RAD) today announced sales results for December.
Monthly Sales
For the four weeks ended Dec. 29, 2012, same store sales decreased 2.2 percent over the prior-year period. December front-end same store sales decreased 1.0 percent. The New Year’s holiday calendar shift had a negative impact of 1.1 percent on front-end same store sales results. Pharmacy same store sales, which included an approximate 605 basis points negative impact from new generic introductions, decreased 2.9 percent. Prescription count at comparable stores increased 4.4 percent over the prior-year period. Increases in flu-related prescriptions and flu shots contributed 1.7 percent of this increase.
Total drugstore sales for the four-week period decreased 2.7 percent to $2.054 billion compared to $2.112 billion for the same period last year. Prescription sales accounted for 62.9 percent of drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales.
Year-to-Date Sales
Same store sales for the 43-week period ended Dec. 29, 2012 increased 0.1 percent over the prior-year period. Front-end same store sales increased 1.4 percent while pharmacy same store sales decreased 0.6 percent. Prescription count at comparable stores increased 3.6 percent over the prior-year period.
Total drugstore sales for the 43 weeks ended Dec. 29, 2012 decreased 0.6 percent with sales of $20.913 billion compared to $21.030 billion for the same period last year. Prescription sales represented 67.4 percent of total drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Monthly Sales
For the four weeks ended Dec. 29, 2012, same store sales decreased 2.2 percent over the prior-year period. December front-end same store sales decreased 1.0 percent. The New Year’s holiday calendar shift had a negative impact of 1.1 percent on front-end same store sales results. Pharmacy same store sales, which included an approximate 605 basis points negative impact from new generic introductions, decreased 2.9 percent. Prescription count at comparable stores increased 4.4 percent over the prior-year period. Increases in flu-related prescriptions and flu shots contributed 1.7 percent of this increase.
Total drugstore sales for the four-week period decreased 2.7 percent to $2.054 billion compared to $2.112 billion for the same period last year. Prescription sales accounted for 62.9 percent of drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales.
Year-to-Date Sales
Same store sales for the 43-week period ended Dec. 29, 2012 increased 0.1 percent over the prior-year period. Front-end same store sales increased 1.4 percent while pharmacy same store sales decreased 0.6 percent. Prescription count at comparable stores increased 3.6 percent over the prior-year period.
Total drugstore sales for the 43 weeks ended Dec. 29, 2012 decreased 0.6 percent with sales of $20.913 billion compared to $21.030 billion for the same period last year. Prescription sales represented 67.4 percent of total drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Rite Aid (RAD) Ramps Higher; Up 8%
- Hastings Entertainment (HAST) Posts Q1 Loss of 27c/Share; Comps Down 4.7%
- Macy's (M) Posts Q1 EPS of 55c; Comps Up 3.8%; Boosts Dividend 25%, Raises Buyback
Create E-mail Alert Related Categories
Retail Sales
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
